10,897 GE HealthCare Technologies Inc. $GEHC Shares Purchased by Rakuten Investment Management Inc.

Rakuten Investment Management Inc. raised its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 9.9% during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 121,395 shares of the company’s stock after purchasing an additional 10,897 shares during the quarter. Rakuten Investment Management Inc.’s holdings in GE HealthCare Technologies were worth $8,068,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. Trian Fund Management L.P. boosted its stake in GE HealthCare Technologies by 76,194.4% in the second quarter. Trian Fund Management L.P. now owns 3,085,344 shares of the company’s stock valued at $197,493,000 after buying an additional 3,081,300 shares in the last quarter. Mizuho Markets Cayman LP lifted its holdings in shares of GE HealthCare Technologies by 173.2% in the first quarter. Mizuho Markets Cayman LP now owns 3,068,500 shares of the company’s stock worth $218,416,000 after acquiring an additional 1,945,500 shares during the last quarter. Barrow Hanley Mewhinney & Strauss LLC lifted its holdings in shares of GE HealthCare Technologies by 13.2% in the second quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 13,455,814 shares of the company’s stock worth $861,307,000 after acquiring an additional 1,571,226 shares during the last quarter. Amundi boosted its stake in shares of GE HealthCare Technologies by 129.9% in the 2nd quarter. Amundi now owns 2,500,094 shares of the company’s stock valued at $160,031,000 after purchasing an additional 1,412,453 shares in the last quarter. Finally, Perpetual Ltd boosted its stake in shares of GE HealthCare Technologies by 107.4% in the 3rd quarter. Perpetual Ltd now owns 2,712,232 shares of the company’s stock valued at $177,299,000 after purchasing an additional 1,404,683 shares in the last quarter. Institutional investors own 82.06% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on GEHC. Barclays upped their price objective on shares of GE HealthCare Technologies from $85.00 to $95.00 and gave the stock an “overweight” rating in a research report on Thursday, October 29th. Bank of America restated a “neutral” rating on shares of GE HealthCare Technologies in a research report on Thursday, October 29th. Oppenheimer reaffirmed an “outperform” rating on shares of GE HealthCare Technologies in a research note on Thursday, July 30th. Evercore reiterated an “outperform” rating and set a $84.00 price target on shares of GE HealthCare Technologies in a report on Thursday, July 30th. Finally, Royal Bank Of Canada upped their price target on shares of GE HealthCare Technologies from $80.00 to $90.00 and gave the stock an “outperform” rating in a report on Thursday, October 29th. Twelve analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $80.87.

GE HealthCare Technologies Stock Performance

NASDAQ:GEHC opened at $83.78 on Friday. The stock’s 50-day moving average is $69.12 and its 200-day moving average is $70.04. GE HealthCare Technologies Inc. has a 1-year low of $58.75 and a 1-year high of $89.77. The company has a current ratio of 1.30, a quick ratio of 1.01 and a debt-to-equity ratio of 0.86. The stock has a market cap of $37.88 billion, a P/E ratio of 17.67, a price-to-earnings-growth ratio of 2.16 and a beta of 0.65.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Wednesday, October 28th. The company reported $1.34 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.20 by $0.14. GE HealthCare Technologies had a net margin of 9.96% and a return on equity of 20.45%. The business had revenue of $5.51 billion during the quarter, compared to analyst estimates of $5.35 billion. During the same quarter last year, the business earned $1.07 EPS. The firm’s quarterly revenue was up 7.2% on a year-over-year basis. Equities research analysts anticipate that GE HealthCare Technologies Inc. will post 5.02 earnings per share for the current year.

GE HealthCare Technologies Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Friday, October 23rd will be given a $0.04 dividend. This is an increase from GE HealthCare Technologies’s previous quarterly dividend of $0.0350. The ex-dividend date is Friday, October 23rd. This represents a $0.16 annualized dividend and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is currently 3.38%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc is a global medical technology company that develops and provides products, services and digital solutions for healthcare providers. Its offerings are designed to support the diagnosis, treatment and monitoring of patients across hospitals, outpatient facilities, imaging centers and other care settings.

The company’s portfolio includes medical imaging systems such as computed tomography, magnetic resonance imaging, molecular imaging, surgical imaging and X-ray equipment.